Current Trends in Lithium and Rubidium Therapy: Proceedings of an International Symposium on Lithium and Rubidium Therapy held in Venice, 29 September–1st October 1983
Editat de G.U. Corsinien Limba Engleză Paperback – 21 mar 2012
Preț: 365.61 lei
Preț vechi: 384.86 lei
-5% Nou
Puncte Express: 548
Preț estimativ în valută:
69.99€ • 72.75$ • 58.03£
69.99€ • 72.75$ • 58.03£
Carte tipărită la comandă
Livrare economică 07-21 februarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9789401173209
ISBN-10: 9401173206
Pagini: 352
Ilustrații: 352 p.
Dimensiuni: 155 x 235 x 18 mm
Greutate: 0.49 kg
Ediția:Softcover reprint of the original 1st ed. 1984
Editura: SPRINGER NETHERLANDS
Colecția Springer
Locul publicării:Dordrecht, Netherlands
ISBN-10: 9401173206
Pagini: 352
Ilustrații: 352 p.
Dimensiuni: 155 x 235 x 18 mm
Greutate: 0.49 kg
Ediția:Softcover reprint of the original 1st ed. 1984
Editura: SPRINGER NETHERLANDS
Colecția Springer
Locul publicării:Dordrecht, Netherlands
Public țintă
ResearchCuprins
I: Introduction and Historical Review.- 1 Recent developments in lithium treatment and research.- 2 Lithium treatment of mania and depression over one hundred years.- II: Mechanism of Action of Lithium and Rubidium.- 3 Some recent and some not-so-recent findings on the behavioural effects of lithium in animals.- 4 Opposite effects of lithium and rubidium on neurohormone-stimulated cyclic AMP accumulation in rat brain.- 5 The effect of rubidium and lithium on adenylate cyclase and neurotransmitter receptors.- 6 Does lithium prevent the development of dopamine receptor supersensitivity? Behavioural studies.- III: Clinical Aspects of Long-Term Lithium Treatment.- 7 Critical issues in the evaluation of long-term lithium treatment.- 8 A prospective study of long-term lithium treatment. An interim report.- 9 Lithium dosage and prophylaxis. A double-blind controlled study.- 10 Lithium discontinuation in bipolar illness: a double-blind prospective controlled study.- 11 Lithium treatment in schizoaffective patients.- 12 Static and kinetic study of the RBC/plasma lithium ratio in manic-depressive, schizoaffective and schizophrenic patients in thymic remission: significance for diagnosis and monitoring.- 13 Lithium prophylaxis in major affective disorders: on the specificity and sensitivity of some “new” predictors of treatment outcome.- 14 Practical value of biological and psychological indicators in predicting response to lithium prophylaxis of manic-depressive psychosis.- 15 Outcome to treatment with lithium in affective patients and family history.- 16 Antidepressant-induced switch and outcome to lithium prophylaxis in bipolar patients.- IV: Clinical Aspects of Long-Term Rubidium Treatment.- 17 Rubidium salts in depressed patients. An open pilot study using standardizedtechniques.- 18 Preliminary results with rubidium in depressed patients.- 19 The use of rubidium chloride in depressive disorders: clinical aspects.- V: New Aspects in Lithium and Rubidium Treatment.- 20 The effect of lithium treatment in humans of psychophysiological increases and decreases in heart rate.- 21 Left ventricular performance following lithium treatment.- 22 Lithium carbonate and granulocyte function during cancer chemotherapy. Preliminary report.- 23 Cancer chemotherapy induced neutropenia: effects of lithium carbonate.- 24 Lithium and rubidium compounds in cluster headache: overview and perspectives.- 25 Lithium therapy in cluster headache. Effect on iris neuro-muscular junction.- 26 Changes in tubular enzymes during acute lithium treatment.- 27 Prophylactic efficacy of carbamazepine in lithium-resistant affective disorders.